NCT00505414 2019-11-01
A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine
Grünenthal GmbH
Phase 3 Terminated
Clinical Trials
4 trialsNCT00446069 2016-08-29
A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients
Egalet Ltd
Phase 2 Completed
NCT00410540 2010-04-27
A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.
Alza Corporation, DE, USA
Phase 3 Completed
NCT00822614 2009-01-14
FINDS
Akela Pharma, Inc.
Phase 3 Unknown